Market Place
Sourcing Support
Tonix Pharmaceuticals to Present at BIO International 2025
10 Jun 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present Poster at Eular 2025
05 Jun 2025 //
GLOBENEWSWIRE
Tonix Pharma to Present at A.G.P. Annual Healthcare Showcase
22 May 2025 //
GLOBENEWSWIRE
Tonix Doses First Patient In Ph2 Oasis Study Of TNX-102 SL
21 May 2025 //
GLOBENEWSWIRE
Tonix Appoints Joseph as GC & Executive VP of Operations
14 May 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Reports Q1 2025 Financial Results
12 May 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Presents Preclinical Data at AACR 2025
29 Apr 2025 //
GLOBENEWSWIRE
Tonix culls cocaine intoxication trial amid enrollment woes
28 Apr 2025 //
FIERCE BIOTECH
Tonix Pharmaceuticals Presents Data on Mpox Vaccine TNX-801
24 Apr 2025 //
GLOBENEWSWIRE
Tonix Pharma Present at World Vaccine Congress Washington 2025
16 Apr 2025 //
GLOBENEWSWIRE
Tonix and Makana Collaborate on Xenotransplantation Studies
09 Apr 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Data on TNX-102 SL for Fibromyalgia at AAPM
07 Apr 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at 2025 Jones Trading Conference
02 Apr 2025 //
GLOBENEWSWIRE
Tonix Pharma Launches TONIX ONE™ Digital Platform for Migraine
01 Apr 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at AAPM 2025 Annual Meeting
27 Mar 2025 //
GLOBENEWSWIRE
Tonix Pharma: FDA Skips Advisory Panel For Tnx-102 SL In Fibromyalgia
24 Mar 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Reports Q4 and Full Year 2024 Results
18 Mar 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals presents at BIO-Europe Spring 2025
13 Mar 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at Zacks SCR Life Sciences
11 Mar 2025 //
GLOBENEWSWIRE
Tonix Pharma Gets MCDC Grant For TNX-801 Mpox, Smallpox Vaccine
10 Mar 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at 2025 Virtual Investor Summit
05 Mar 2025 //
GLOBENEWSWIRE
Tonix Presents TNX-102 SL Data At Fibromyalgia Congress
04 Mar 2025 //
GLOBENEWSWIRE
Tonix Announces Preliminary 2024 Results & Year-End Cash
07 Feb 2025 //
GLOBENEWSWIRE
Tonix Report Positive Ph 1 Result for TNX-1500 in Kidney Transplant
06 Feb 2025 //
GLOBENEWSWIRE
Tonix Pharma to Participate in 2025 BIO CEO & Investor Conference
05 Feb 2025 //
GLOBENEWSWIRE
Tonix Pharma Promotes Siobhan Fogarty to Chief Technical Officer
04 Feb 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split
03 Feb 2025 //
GLOBENEWSWIRE
Tonix Pharma Appoints Gary Ainsworth As VP Of Market Access
08 Jan 2025 //
GLOBENEWSWIRE
Tonix To Present At Two Investor Conferences This January
07 Jan 2025 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces PDUFA Goal Date for Fibromyalgia
23 Dec 2024 //
GLOBENEWSWIRE
Tonix Announces FDA Acceptance of TNX-102 SL NDA for Fibromyalgia
17 Dec 2024 //
GLOBENEWSWIRE
Tonix`s TNX 102-SL Offers New Hope for Fibromyalgia Pain
09 Dec 2024 //
ACCESSWIRE
Tonix Pharma Expands Leadership Team with Two Strategic Hires
03 Dec 2024 //
GLOBENEWSWIRE
Tonix Pharma to Participate in NobleCon20 Investor Conference
26 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharma Presents TNX-102 SL Data for Fibromyalgia at ACR 2024
18 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharma to Present at Winter 2024 Investor Summit Virtual
18 Nov 2024 //
GLOBENEWSWIRE
Tonix Targets Rapid Migraine Relief With Non-Oral Treatments
14 Nov 2024 //
ACCESSWIRE
Tonix Pharma Publishes Mpox & Smallpox Vaccine Study in mSphere
13 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharma Announces Poster at ACR Convergence Annual Meeting
13 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharma Reports Q3 2024 Financial Results & Operational
12 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharma Announces Mpox Phase I Study Agreement with KEMRI
04 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at BIO-Europe® 2024
29 Oct 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference
25 Oct 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals To Present At World Vaccine Congress
24 Oct 2024 //
GLOBENEWSWIRE
Tonix Receives Contract Payment For Antiviral Development
17 Oct 2024 //
GLOBENEWSWIRE
Tonix Submits TNX-102 SL NDA For Fibromyalgia To The FDA
16 Oct 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces AI Collaboration With X-Chem
08 Oct 2024 //
GLOBENEWSWIRE
Two Companies Near FDA Decisions On Non-Addictive Painkillers
01 Oct 2024 //
ACCESSWIRE
Tonix Pharma Joins Endpoints Panel At Long COVID Workshop
30 Sep 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Patent For Zembrace SymTouch
27 Sep 2024 //
GLOBENEWSWIRE
Tonix Announces TNX-102 SL Presentations At PDDS 2024
23 Sep 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Issuance Of U.S. Patent
19 Sep 2024 //
GLOBENEWSWIRE
Tonix`s Mpox Vaccine Aligns With WHO`s Target Profile
16 Sep 2024 //
GLOBENEWSWIRE
Tonix Appoints Thomas Englese As EVP Commercial Operations
10 Sep 2024 //
GLOBENEWSWIRE
Tonix Presents Data On Potential Mpox Vaccine TNX-801
09 Sep 2024 //
GLOBENEWSWIRE
Tonix Launches Campaign On Gastroparesis Impact On Migraine Meds
06 Sep 2024 //
GLOBENEWSWIRE
Tonix Presents TNX-102 SL Data for Stress Reduction and Wound Healing at MHSRS
29 Aug 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Presented TNX-102 SL Data At MHSRS 2024
28 Aug 2024 //
GLOBENEWSWIRE
Tonix and Bilthoven Collaborate on Mpox Vaccine Development, TNX-801
26 Aug 2024 //
GLOBENEWSWIRE
Tonix And Bilthoven Biologicals To Collaborate On Mpox Vaccine Development
26 Aug 2024 //
GLOBENEWSWIRE
